Clinical Trials Browser

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Myoepithelioma, Sarcoma, Ewing, Liposarcoma, Myxoid, Sarcoma, Clear Cell, Desmoplastic Small Round Cell Tumor

NCT04690725 2020-12-31

TQBSP

Phase 1/2 Unknown

29 enrolled

Sarcoma

Chondrosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT04433221 2020-06-16

Combination Immunotherapy Targeting Sarcomas

Phase 1/2 Unknown

20 enrolled

Sarcoma

Bone Neoplasms, Sarcoma, Sarcoma, Ewing

NCT03356782 2020-06-11

Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

Phase 1/2 Unknown

20 enrolled

Sarcoma

Diabetes Mellitus, Insulin-Dependent, 12, Bone Neoplasms, Sarcoma, Sarcoma, Ewing

NCT02409576 2019-04-16

NKEXPSARC

Phase 1/2 Unknown

20 enrolled

Sarcoma

Rhabdomyosarcoma, Sarcoma, Ewing

NCT03416517 2019-02-15

Anlotinib and Irinotecan for Ewing Sarcoma

Phase 1/2 Unknown

47 enrolled

Sarcoma

Neoplasm Metastasis, Sarcoma, Ewing

NCT00179816 2010-10-11

Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors

Phase 1/2 Unknown

12 enrolled

GastrointestinalGenitourinaryLymphoidSarcoma

Hodgkin Disease, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Sarcoma, Sarcoma, Ewing, Hepatoblastoma

Clinical Trials

A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)

TQBSP

Combination Immunotherapy Targeting Sarcomas

Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

NKEXPSARC

Anlotinib and Irinotecan for Ewing Sarcoma

Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors